Indication:
Dosage & Administration:
No dosage adjustment is required in patients with mild, moderate, or severe renal impairment.Tenofovir Alafenamide is not recommended in patients with end stage renal disease (estimated creatinine clearance below J 5 mL/min).
No dosage adjustment is required in patients with mild hepatic impairment (Child-Pugh A). Tenofovir Alafenamide is not recommended in patients with decompensated (Child-Pugh B or C) hepatic impairment.
Preparation: